These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks says Arch Capital Group (ACGL) and CME Group (CME) have positive Earnings ESPs ahead of their next reports: ACGL’s estimate is $2.39 per share versus $1.92 consensus (+24.57%), while CME’s is $2.94 versus $2.93 (+0.26%). Both carry a Zacks Rank #3 (Hold); the article cites a Zacks 10-year backtest in which positive ESP combined with a rank of #3 or better preceded a positive earnings surprise 70% of the time and produced roughly 28% average annual returns.

Analysis

Treat the screen as an estimate-revision alert, not evidence of durable earnings alpha. A reported beat can still disappoint if the revisions are stale, already reflected in the share price, or driven by low-quality items; the cited backtest does not establish current, tradable expectancy after costs or event volatility.

ACGL’s unusually wide estimate gap is the only signal worth investigating. For an insurer/reinsurer, the key distinction is whether earnings strength comes from underlying underwriting and investment income or from favorable catastrophe experience and reserve development. A headline beat without resilient underwriting metrics may not support a rerating; catastrophe losses or adverse reserve revisions can overwhelm a modest estimate edge. CME’s estimate gap is too narrow to offer much standalone information. Its earnings sensitivity is more plausibly tied to realized client activity and product mix than to a tiny consensus mismatch, so inspect volume and contract mix rather than trade the screen.

Near term, the October reports are binary catalysts; over 1–3 months, guidance and the quality of earnings matter more than the beat itself. Over 6–18 months, ACGL remains exposed to catastrophe/reinsurance-cycle changes, while CME’s activity can normalize if volatility and hedging demand fade. The contrarian point: “beat probability” is not the same as positive post-report return, particularly when expectations are already embedded or the beat is low quality. Verify estimate-revision recency and dispersion, current implied volatility, and valuation before sizing either event.

Key Decisions for Investors

• ACGL: put on an event watch, not an unconditional pre-earnings long. Confirm the estimate gap reflects fresh, independent analyst revisions; if corroborated and price action has not already discounted it, consider a small, defined-risk bullish position. Avoid naked calls unless option pricing supports the risk.
• ACGL: on the report, require evidence in underlying underwriting results, catastrophe losses, and reserve development before adding. A beat accompanied by weaker underwriting quality or adverse reserve signals falsifies the bullish read; reassess on any guidance or loss-development deterioration.
• CME: no trade on the marginal estimate signal alone. Track trading volume and contract mix, including rate-sensitive activity; consider a bullish position only if reported activity and forward commentary exceed what market pricing implies.
• Before either event, compare option-implied move with historical post-earnings moves and check estimate timestamps, dispersion, and recent price performance. If the implied move is already expensive or revisions are not independently corroborated, stay flat rather than pay for an uncertain surprise.